144 related articles for article (PubMed ID: 37537511)
1. The impact of boost radiation therapy after hysterectomy on cervical cancer patients with close or positive resection margins.
Lee SJ; Kim M; Kwak YK; Kang HJ
Clin Transl Oncol; 2024 Mar; 26(3):689-697. PubMed ID: 37537511
[TBL] [Abstract][Full Text] [Related]
2. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.
Sandler KA; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Song DY; Klein EA; Stephenson AJ; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco SC; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR; Kishan AU
Eur Urol; 2020 Jan; 77(1):3-10. PubMed ID: 30992160
[TBL] [Abstract][Full Text] [Related]
3. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.
Amini A; Jones BL; Yeh N; Rusthoven CG; Armstrong H; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1052-63. PubMed ID: 26581142
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins.
Lee YH; Kim YS; Choi KH; Sung S; Jeong BK; Ha IB; Kang KM; Lee J; Lee JH; Kim SH
Int J Clin Oncol; 2022 Jan; 27(1):202-212. PubMed ID: 34677738
[TBL] [Abstract][Full Text] [Related]
5. Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
Shan M; Deng Y; Zou W; Fan S; Li Y; Liu X; Wang J
BMC Cancer; 2023 Sep; 23(1):905. PubMed ID: 37752476
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.
Ta MH; Schernberg A; Giraud P; Monnier L; Darai É; Bendifallah S; Schlienger M; Touboul E; Orthuon A; Challand T; Huguet F; Rivin Del Campo E
Acta Oncol; 2019 Aug; 58(8):1127-1134. PubMed ID: 31017032
[No Abstract] [Full Text] [Related]
7. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation by intensity-modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease.
Khosla D; Patel FD; Rai B; Chakraborty S; Oinam AS; Sharma SC
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):e1-6. PubMed ID: 22889568
[TBL] [Abstract][Full Text] [Related]
9. Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.
Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
[TBL] [Abstract][Full Text] [Related]
10. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
[TBL] [Abstract][Full Text] [Related]
11. Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer.
Wang SC; Ting WC; Chang YC; Yang CC; Lin LC; Ho HW; Chu SS; Lin YW
Front Oncol; 2020; 10():814. PubMed ID: 32547949
[No Abstract] [Full Text] [Related]
12. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
13. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
Ziebarth AJ; Smith H; Killian ME; Nguyen NA; Durst JK; Subramaniam A; Kim KH; Leath CA; Straughn JM; Alvarez RD
Gynecol Oncol; 2012 Jul; 126(1):69-72. PubMed ID: 22484400
[TBL] [Abstract][Full Text] [Related]
14. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Roach M; Moughan J; Lawton CAF; Dicker AP; Zeitzer KL; Gore EM; Kwok Y; Seider MJ; Hsu IC; Hartford AC; Horwitz EM; Yamoah K; Jones CU; Michalski JM; Lee WR; Pisansky TM; Rabinovitch R; Rotman M; Pryzant RM; Kim HE; Thomas CR; Shipley WU; Sandler HM
Lancet Oncol; 2018 Nov; 19(11):1504-1515. PubMed ID: 30316827
[TBL] [Abstract][Full Text] [Related]
15. Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer - a retrospective analysis of dose-escalated patients.
Link C; Honeck P; Makabe A; Giordano FA; Bolenz C; Schaefer J; Bohrer M; Lohr F; Wenz F; Buergy D
Radiat Oncol; 2019 Jun; 14(1):96. PubMed ID: 31174555
[TBL] [Abstract][Full Text] [Related]
16. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
18. External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume.
Tharmalingam H; Tsang Y; Choudhury A; Alonzi R; Wylie J; Ahmed I; Henry A; Heath C; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):525-533. PubMed ID: 31610249
[TBL] [Abstract][Full Text] [Related]
19. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.
Mundt AJ; Roeske JC; Lujan AE; Yamada SD; Waggoner SE; Fleming G; Rotmensch J
Gynecol Oncol; 2001 Sep; 82(3):456-63. PubMed ID: 11520140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]